Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

In today’s world, where instant delivery and ride-sharing are everyday norms, healthcare access still lags behind. Patients now wait an average of 31 days to see a specialist in major U.S. cities—a 19 percent jump since 2022—according to AMN Healthcare’s 2025 survey. The stakes are high: delays can lead to worsening conditions, increased ER visits,…

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Geoffrey M. Roche, SVP of Healthcare Solutions at Risepoint and a lifelong advocate for healthcare workforce development. With a career shaped by his mother’s journey as a nurse, Geoff shares how personal inspiration, industry insight, and bold leadership are reshaping…

Artificial intelligence is rapidly transforming healthcare diagnostics, with some of the most promising breakthroughs happening in cardiology. Structural heart disease affects millions and frequently goes undiagnosed in its early stages, leaving patients vulnerable to serious complications. One such condition, severe aortic stenosis, often remains unnoticed until it becomes life-threatening—carrying a two-year mortality rate worse…